Bowhead Specialty (NYSE:BOW - Get Free Report) is anticipated to post its Q1 2025 quarterly earnings results before the market opens on Tuesday, May 6th. Analysts expect Bowhead Specialty to post earnings of $0.34 per share and revenue of $105.17 million for the quarter.
Bowhead Specialty (NYSE:BOW - Get Free Report) last issued its quarterly earnings data on Tuesday, February 25th. The company reported $0.42 EPS for the quarter, topping the consensus estimate of $0.35 by $0.07. The business had revenue of $184.77 million for the quarter, compared to analyst estimates of $102.12 million. On average, analysts expect Bowhead Specialty to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.
Bowhead Specialty Stock Up 0.1 %
NYSE:BOW traded up $0.04 on Tuesday, reaching $40.46. The company's stock had a trading volume of 21,017 shares, compared to its average volume of 212,922. Bowhead Specialty has a 1-year low of $22.14 and a 1-year high of $42.29. The business's 50-day moving average price is $37.39 and its two-hundred day moving average price is $34.66.
Insider Activity at Bowhead Specialty
In other Bowhead Specialty news, Director Ava Schnidman acquired 1,493 shares of Bowhead Specialty stock in a transaction dated Friday, February 28th. The stock was bought at an average cost of $33.41 per share, for a total transaction of $49,881.13. Following the purchase, the director now directly owns 1,893 shares in the company, valued at approximately $63,245.13. This represents a 373.25 % increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link.
Analyst Ratings Changes
A number of research firms recently issued reports on BOW. Keefe, Bruyette & Woods lowered their target price on Bowhead Specialty from $44.00 to $43.00 and set an "outperform" rating for the company in a research note on Wednesday, April 9th. JPMorgan Chase & Co. raised their price objective on shares of Bowhead Specialty from $30.00 to $35.00 and gave the stock a "neutral" rating in a report on Tuesday, April 8th. Piper Sandler began coverage on shares of Bowhead Specialty in a research note on Wednesday, April 16th. They issued an "overweight" rating and a $44.00 target price for the company. Finally, JMP Securities lifted their price target on Bowhead Specialty from $38.00 to $40.00 and gave the company a "market outperform" rating in a research note on Friday, April 11th. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, Bowhead Specialty presently has an average rating of "Moderate Buy" and an average target price of $37.17.
Get Our Latest Stock Analysis on Bowhead Specialty
About Bowhead Specialty
(
Get Free Report)
Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Bowhead Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bowhead Specialty wasn't on the list.
While Bowhead Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.